Fighting invasive oral cancer at age 51 forced Sotinsky to confront the existential importance of the human voice. Her unique ...

Designed with our proprietary AI-Immunology™ platform based on patient sequencing data, EVX-04 targets multiple non-conventional endogenous retrovirus (ERV) tumor antigensEVX-04 induces targeted ...

Metsera has several potential big winners in its pipeline, but the most promising might be its experimental obesity drugs MET ...

‘Chief Medical Officer’s Annual Report 2025: Infections’ was published at 15:00 UK time on Thursday the 4th of December 2025. Prof Andrew Morris: Andrew is the President of the Academy of Medical ...

The partners will also leverage AI tools and proprietary evaluation models to home in on targetable shared cancer antigens and develop vaccines against them.

Cancer isn't just about broken genes—it's about broken architecture. Imagine a city where roads suddenly vanish, cutting off ...

A new nanoparticle vaccine successfully prevented several aggressive cancers in mice, including pancreatic and melanoma. The ...

Dr. Vadim Jucaud's lab at the Terasaki Institute has introduced a new organ-on-a-chip platform that recapitulates ...

An experimental vaccine has saved lives in an early clinical trial for a rare form of liver cancer that primarily affects younger patients, researchers with Johns Hopkins Kimmel Cancer Center ...

Dr. Vadim Jucaud's lab at the Terasaki Institute has introduced a new organ-on-a-chip platform that recapitulates ...

For both health systems and investors, the most exciting signal is how AI amplifies advances in biotechnology.

A reshaped vaccine committee voted to scale back newborn hepatitis B shots despite decades of data showing the birth dose is safe, effective and vital.